Therapeutic Approach for Chikungunya Infection

Authors: Markovnikov Reagan C , Prasad VN , Gopikumar MS and Honnavar P

DOI: 10.23880/vij-16000177

Volume 2, Issue 7

Abstract

Chikungunya is endemic to sub-Saharan Africa and South and East Asia, in recent years, it has been expanding its horizon due to increasing international travel. Patients present with fever, headache, rash and severe symmetrical polyarthralgia. More than a million Chikungunya viral cases are reported annually, which can hamper individual’s quality of life and most of the time they undergo long-term rheumatologic complaints. Despite the copious amount of extensive and prolonged research that has been conducted by researchers, an effective novel and potent anti-Chikungunya drug has yet to be developed. This review provides an overview on currently available treatments, and recent findings and progress in the development of major therapeutic strategies that are being evaluated as treatments for Chikungunya virus induced disease.

Keywords: Chikungunya; Infection

View PDF